Single dose nonavalent HPV vaccine – need of the hour

Authors

  • Soma Bandyopadhyay
  • Manidip Pal College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal. India

DOI:

https://doi.org/10.3126/nje.v10i2.28962

Keywords:

HPV, Nonavalent, Quadrivalent, Single dose, Vaccine

Abstract

HPV vaccination of the 9-14 years girl children is the answer to eradicate carcinoma cervix. Nonavalent vaccine provides wider coverage than the quadrivalent vaccine. On long-term follow-up, even after single dose HPV vaccination, antibody titre remains good. Herd immunity also achieved by HPV vaccine. Hence single dose nonavalent HPV vaccination of mass people (sexually naive 9-14 years girl children) can provide almost 100% protections and this will be cost-effective also for developing country.  

Downloads

Download data is not yet available.
Abstract
413
PDF
407

Author Biographies

Soma Bandyopadhyay

(Formerly) Associate Professor, Department of Obstetrics & Gynecology, G.S.L.Medical College & General Hospital, NH-5, Lakshmipuram, Rajahmundry, Andhrapradesh

Manidip Pal, College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal. India

Professor & HOD,

Department of Obstetrics & Gynecology

College of Medicine & JNM Hospital, WBUHS,

Kalyani, Nadia, West Bengal. India

email address: manideep2b@yahoo.com

Downloads

Published

2020-06-30

How to Cite

Bandyopadhyay, S., & Pal, M. (2020). Single dose nonavalent HPV vaccine – need of the hour. Nepal Journal of Epidemiology, 10(2), 871–873. https://doi.org/10.3126/nje.v10i2.28962

Issue

Vol. 10 No. 2 (2020)

Section

Short Communications

License

  • Upon acceptance Copyright on any research article is transferred in full to the Confederation of Epidemiological Associations (CEA) and International Nepal Epidemiological Association (INEA).  The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).
  • Articles in the Nepal Journal of Epidemiology are Open Access articles published under the Creative Commons CC BY License (https://creativecommons.org/licenses/by/4.0/)
  • This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.